Abstract
Background: Fascioliasis is a neglected tropical disease that affects poor people from poor and developing countries. In the world, it has been estimated that at least 2.6 million people are affected with this disease. The International agency for Research on Cancer, states that O. viverrini and C. sinensis, also liver flukes, are considered as definitive causes of cholangiocarcinoma. However, fascioliasis caused by F. hepatica has not been associated with cancer to date. There are not any known causative associations between this parasite and liver cancer (cholangiocarcinoma).
Methods: Chine Hamster Ovary (CHO) cells were treated with F. haepatica extracts and cell proliferation was assessed by using the indirect method for estimating cell number based on the mitochondrial activity with MTS cell proliferation reagent.
Results: We observed unexpected death of these cells when treated with F. haepatica extracts.
Conclusion: We now hypothesize that this parasite could be used as a medically-important trematode pathogen in cancer therapy.
Keywords: Fasciola hepatica, mammalian cells, cholangiocarcinoma, O. viverrini, C. sinensis, Chine Hamster Ovary (CHO).
Anti-Infective Agents
Title:Fasciola Hepatica Extract Induces Cell Death of Mammalian Cells
Volume: 16 Issue: 2
Author(s): Stephanie Ferreira, Ruben Fernandes and Monica C. Botelho*
Affiliation:
- I3S, Instituto de Investigacao e Inovacao da Universidade do Porto, Porto,Portugal
Keywords: Fasciola hepatica, mammalian cells, cholangiocarcinoma, O. viverrini, C. sinensis, Chine Hamster Ovary (CHO).
Abstract: Background: Fascioliasis is a neglected tropical disease that affects poor people from poor and developing countries. In the world, it has been estimated that at least 2.6 million people are affected with this disease. The International agency for Research on Cancer, states that O. viverrini and C. sinensis, also liver flukes, are considered as definitive causes of cholangiocarcinoma. However, fascioliasis caused by F. hepatica has not been associated with cancer to date. There are not any known causative associations between this parasite and liver cancer (cholangiocarcinoma).
Methods: Chine Hamster Ovary (CHO) cells were treated with F. haepatica extracts and cell proliferation was assessed by using the indirect method for estimating cell number based on the mitochondrial activity with MTS cell proliferation reagent.
Results: We observed unexpected death of these cells when treated with F. haepatica extracts.
Conclusion: We now hypothesize that this parasite could be used as a medically-important trematode pathogen in cancer therapy.
Export Options
About this article
Cite this article as:
Ferreira Stephanie , Fernandes Ruben and C. Botelho Monica *, Fasciola Hepatica Extract Induces Cell Death of Mammalian Cells, Anti-Infective Agents 2018; 16 (2) . https://dx.doi.org/10.2174/1570180815666180531102555
DOI https://dx.doi.org/10.2174/1570180815666180531102555 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Significance of P2X7 Receptor Variants to Human Health and Disease
Recent Patents on DNA & Gene Sequences Diabetes-induced Epigenetic Signature in Vascular Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Hybrid Compounds & Oxidative Stress Induced Apoptosis in Cancer Therapy
Current Medicinal Chemistry Anticancer Drugs Discovery and Development from Marine Organisms
Current Topics in Medicinal Chemistry Dual Role of S100A8 and S100A9 in Inflammation-Associated Cancer
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Population Pharmacogenomics and Personalized Medicine Research in Hungary: Achievements and Lessons Learned
Current Pharmacogenomics and Personalized Medicine Recent Advances in Delivery of Cytokines, Growth Factors, and Molecules of Therapeutic Interest from Hyaluronan-based Hydrogels
Current Tissue Engineering (Discontinued) Interaction of Tumor Suppressor p53 with DNA and Proteins
Current Pharmaceutical Biotechnology Plumbagin: A Potential Anti-cancer Compound
Mini-Reviews in Medicinal Chemistry New Molecules and Strategies in the Field of Anticancer Agents
Current Medicinal Chemistry - Anti-Cancer Agents Identification and Characterization of SNP Mutation in Genes Related to Non-small Cell Lung Cancer
Current Signal Transduction Therapy Substrate Spectra of Nucleoside Phosphorylases and their Potential in the Production of Pharmaceutically Active Compounds
Current Pharmaceutical Design Bombacaceae Between the Ethnomedical Uses and Pharmacological Evidences: A Review
The Natural Products Journal Tyrphostins as Potential Therapeutic Agents for Acute Kidney Injury
Current Medicinal Chemistry Microarray-Based Gene Expression Analysis of Hepatocellular Carcinoma
Current Genomics Spirooxindoles as Potential Pharmacophores
Mini-Reviews in Medicinal Chemistry Pyrrolizines as Potential Anticancer Agents: Design, Synthesis, Caspase-3 activation and Micronucleus (MN) Induction
Anti-Cancer Agents in Medicinal Chemistry Natural Compounds as Antagonists of Canonical Wnt/β-Catenin Signaling
Current Chemical Biology Biosafety Challenges for Use of Lentiviral Vectors in Gene Therapy
Current Gene Therapy Dynamics of CD86 Expression on Allergic Inflammation - New Insights
Recent Patents on Inflammation & Allergy Drug Discovery